Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib O.F. Olmez; A. Bilici; P. Gursoy; E. Cubukcu; A. Sakin; T. Korkmaz; I. Cil; B. Cakar; S. Menekse; T. Demir; O. Acikgoz; J. Hamdard;

Unresectable stage III non-small cell lung cancer: Insights from a Portuguese expert panel A. Araújo; A. Barroso; B. Parente; C. Travancinha; E. Teixeira; F. Martelo; G. Fernandes; G. Paupério; H. Queiroga; I. Duarte; J.D. da Costa; M. Soares; P. Borralho; P. Costa; P. Chinita; T. Almodôvar; F. Barata;

Polymorphisms and haplotypes of TOLLIP and MUC5B are associated with susceptibility and survival in patients with fibrotic hypersensitivity pneumonitis P.C. Mota; M.L. Soares; A.C. Ferreira; R.F. Santos; J.C. Rufo; D. Vasconcelos; A. Carvalho; S. Guimarães; F. Vasques-Nóvoa; C. Cardoso; N. Melo; A.T. Alexandre; D. Coelho; H. Novais-Bastos; A. Morais;